Mounjaro Summit- Chronic Weight Management and Type 2 Diabetes Management with our local & International Experts

Introduction

Take This Event

Sharing together the new treatment approach of Chronic Weight Management and Type 2 Diabetes by discussing Phase lll SURMOUNT and SURPASS trial programs of the first and only GLP-1/GIP receptor agonist, along with clinical cases and clinical practice from our local and international experts.

Objectives

-To share knowledge and experience with Mounjaro for Chronic Weight Management and Type 2 Diabetes.
-Discussing the first GIP & GLP-1 receptor agonist by sharing Phase III SURMOUNT and SURPASS trial programs along with real life clinical practice and clinical cases.
-Answer Q&A regarding treatment approach of Chronic Weight Management and Type 2 Diabetes

Speaker

Ali Alshehri

Consultant & Chairman of Obesity Medicine Department, (Obesity, Endocrine and Metabolism Center) at King Fahad Medical City, Riyadh, Saudi Arabia

Professor Carel le Roux

The Chair in Chemical Pathology and Metabolic Medicine, University College Dublin and Director of the Metabolic Medicine Group.
Professor of Metabolic Medicine at Ulster University
Extra-ordinary Professor of Chemical Pathology at University of Pretoria.
Coordinates an Innovative Medicine Initiative project on obesity

Fahad Alsabaan

Consultant adult endocrinologist Director diabetes care center. Security Forces Hospital Riyadh